Related Experiment Video
Updated: Jun 26, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured
Greg Maynard1, Joshua Lee, Gerard Phillips
1Division of Hospital Medicine, University of California, San Diego, San Diego, California, USA. gmaynard@ucsd.edu
Background:
Structured subcutaneous insulin order sets and insulin protocols are widely advocated. The intervention effects are not well reported.
Objective:
Assess the impact of these interventions on insulin use patterns, hypoglycemia, and glycemic control.
Design:
Prospective observational.
Setting:
400-bed academic center.
Patients:
Adult non-critical care inpatients with diabetes or hyperglycemia and point-of-care (POC) glucose testing.
Interventions:
Structured insulin orders, insulin management algorithm.
Measurements:
Percent of insulin orders with basal insulin. Percent uncontrolled patient-stays (day-weighted mean glucose >or=180 mg/dL) and uncontrolled patient-days (patient-day mean glucose >or=180 mg/dL). Percent of monitored patient-days and patient-stays with hypoglycemia (glucose
Results:
The percent sliding scale only insulin regimens decreased (72% versus 26% with structured insulin orders, P < 0.0001 chi square). The percent of uncontrolled patient-days was 37.8% versus 33.9% versus 30.1% (P < 0.005) (TP1-Baseline; TP2-Structured insulin orders; TP3-Orders plus Algorithm). Expressed as relative risk with 95% confidence interval (RR with CI), the RR of an uncontrolled patient-stay was reduced from baseline to 0.91 (CI 0.85-0.96) in TP2, and to 0.84 (CI 0.77-0.89) in TP3, with more marked effects in the secondary analysis limited to patients with at least 8 POC values. The percent of patient-days with hypoglycemia was 3.8%, 2.9%, and 2.6% in 3 time periods, representing a RR for hypoglycemic day in TP3:TP1 of 0.68 (CI 0.59-0.78). Similar reductions were seen in risk for hypoglycemic patient-stays.
Conclusions:
Hypoglycemia and glycemic control can be improved simultaneously with structured insulin orders and management algorithms.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Glinides
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Dipeptidyl Peptidase 4 Inhibitors